The Race to Prepare for Medicare’s New Drug Pricing Powers
Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
Read MoreCongress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
Read MoreStacie Dusetzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.
Read MoreIndependent abortion funds have been flooded with donations post-Roe. How do these funds work and what role will they play in a post-Roe world?
Read MoreWhy has a little-known program designed to help hospitals and clinics that serve low-income people become so controversial?
Read MoreBenedic Ippolito shares new research that examines whether hospitals with higher prices also offer higher quality care.
Read MoreAditi Sen shares new research that examines whether hospital consolidation increases health care prices.
Read MoreWe explore cascades of care — how a clinician’s desire to be thorough can snowball into a harmful spiral of unnecessary care.
Read MoreThe Biden administration is trying to close a gap in the Affordable Care Act that blocks 5 million people from getting affordable health care.
Read MoreStacie Dusetzina shares new research on how much extra care comes after different kinds of breast cancer screenings.
Read MoreBianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.
Read More